Home 2019

Archives

FDA proposes new mammography amendments

On March 27, the FDA announced proposed amendments designed to provide more information for patients, including information about breast density. Read more at FDA.gov.

AHRQ new app improves efficiency, patient engagement

AHRQ’s free Question Builder App helps patients and caregivers prepare for medical appointments and maximize visit time. Read more at the Agency for Healthcare Research...

FDA approves first drug for postpartum depression

On March 19, the FDA approved Zulresso (brexanolone) injection for intravenous (IV) use for the treatment of postpartum depression. Zulresso will be available only...
young adults opioids after surgery

Young adults’ use of opioids after surgery

Having a family member with persistent opioid use may be a risk factor for young adults (aged 13 to 21 years) continuing prescriptions long...
fda approves first interoperable insulin pump

FDA approves first interoperable insulin pump

On Feb. 14, the FDA approved Tandem Diabetes Care t:Slim X2 insulin pump with interoperable technology (interoperable t:Slim X2). This new type of insulin...
tobacco youth rises

Use of tobacco products by youth rises

According to a Feb. 11 statement by the FDA, about 4.9 million middle and high school students had used were current users (used in...
treatment acquired ttp

FDA approves first treatment for acquired TTP

On Feb. 6, the FDA approved Cablivi (caplacizumab-yhdp) injection, the first therapy indicated, in combination with plasma exchange and immunosuppressive therapy, for the treatment...
cilostazol aspirin clopidogrel reduces recurrent stroke

Cilostazol, in combination with aspirin or clopidogrel, reduces risk for recurrent stroke

A study presented on Feb. 6 at the American Stroke Association’s International Stroke Conference finds that stroke survivors who take cilostazol in combination with...
manage severe atopic dermatitis

Strategies to manage severe atopic dermatitis

An article in the Journal of Allergy and Clinical Immunology provides strategies for managing severe atopic dermatitis, including the use of biologics. Read more via...
AI quality life cancer

Artificial intelligence for quality of life symptom disturbance in patients with cancer

A study in PLOS One journal reports that researchers have created two machine learning models that can accurately predict the severity of three common...
test breast milk nutrients

FDA approves diagnostic test for breast milk nutrients

On December 21, 2018, the FDA approved the Miris Human Milk Analyzer, a new diagnostic test to help clinicians measure nutrients in breast milk,...
treatments rare blood diseases

FDA approves treatments for two rare blood diseases

On Dec. 21, the FDA approved Ultomiris (ravulizumab) injection for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria and approved Elzonris (tagraxofusp-erzs) infusion...
mexiletine

Who will benefit from mexiletine?

Researchers have identified a technique to determining which patients with a genetic mutation that cause long QT Syndrome type 3 will benefit from mexiletine. Read more via...